Showing results (161-170 of 187) with videos related to
Sort By:
Pageof 19
Oncotarget|February 6, 2014
Role of miR-34a as a suppressor of L1CAM in endometrial carcinomaUwe Schirmer, Kai Doberstein, Anne-Kathleen Rupp, et al.Molecular Cancer|September 18, 2012
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortiumStefanie Aust, Anna Bachmayr-Heyda, Petra Pateisky, et al.Journal of Ovarian Research|July 2, 2013
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortiumFabian Trillsch, Linn Woelber, Christine Eulenburg, et al.European Journal of Cancer (Oxford, England : 1990)|December 24, 2015
Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancerSandrina Lambrechts, Dominiek Smeets, Matthieu Moisse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept StudyElisabeth Maritschnegg, Yuxuan Wang, Nina Pecha, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivoNicole Concin, Gerda Hofstetter, Astrid Berger, et al.Oncotarget|January 2, 2018
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortiumEva Obermayr, Natalia Bednarz-Knoll, Beatrice Orsetti, et al.Oncology Reports|December 3, 2011
MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancerGerda Hofstetter, Astrid Berger, Eva-Maria Bauer, et al.Gynecologic Oncology|October 16, 2012
Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortiumAndreas Melmer, Linda Fineder, Claudia Lamina, et al.International Journal of Cancer|October 29, 2011
Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancerFrederik Marmé, Thomas Hielscher, Sarah Hug, et al.Pageof 19